THE
SCIENCE
Response to a standardized treatment is anything but standard.
Rates of overweight and obesity have been on the rise for decades. We know that weight loss is essential to reduce risk of comorbidities, to extend years of life, and to optimise the quality of life in those years. Yet, no single solution has been shown to lead to consistent successful weight loss and, more importantly, maintenance of that weight loss.
Our technology targets the multifactorial nature of weight loss by acknowledging that diet, lifestyle, biology, behavior and the gut microbiome all play an important role in weight and health.
VARIABLE TREATMENT RESPONSES REQUIRE PERSONALIZED SOLUTIONS
Variability is seen in all modalities of obesity treatment.
This is due to the multifactorial individuality of obesity.
Our technology targets this variability to adapt to individual needs in order to optimize outcomes.
Impact of dietary modifications on the gut microbiome
Our research looks at how dietary factors can significantly modify the quality and functionof the gut microbiota. Our clinical trial digs further into this question, and takes it a step further to see how it is all linked with weight loss.
Big data
Thanks to our extensive phenotypic database of subject data and microbiome analyses, we continue to explore how a holistic look at an individual can optimize their weight loss and health.
The microbiome
We know that the gut microbiome is a super integrator, reacting to environmental and lifestyle inputs and informing metabolism as a result. Our look at the microbiome focuses on not only the composition, but also the function. We know that it is really how the bacterial species behave that can give valuable insights on health outcomes.
OUR "REAL LIFE"
LONGITUDINAL
CLINICAL TRIAL
OUR
TECHNOLOGY
WE BUILT A UNIQUE IN-SILICO
MODELING CORE (IMC)
Our patented IMC technology was built on years of research and development, and draws upon our rich dataset and in-house algorithms to model the functional complexity of the microbiome.
Our technology is at the core of our marketed solutions.
Want to learn more? Access our learning center here.
OUR PUBLICATIONS
Exploring Semi-Quantitative Metagenomic Studies Using Oxford Nanopore Sequencing: A Computational and Experimental Protocol
Protein Supplementation During an Energy-Restricted Diet Induces Visceral Fat Loss and Gut Microbiota Amino Acid Metabolism Activation: A Randomized Trial
Protein Intake, Metabolic Status and the Gut Microbiota in Different Ethnicities: Results from Two Independent Cohorts